Clinicians remain accountable for the accuracy of the medical record, even when AI generates the first draft. IT and governance teams should own the control environment, including storage, access, retention, and compliance requirements. Leadership should also define scope of use, escalation paths, and review processes so responsibility does not become fragmented across departments.
Who is accountable when AI scribes draft the note?
The accountability line should stay with the clinician because the note is part of the medical record, not a draft owned by the tool. AI can assist with transcription, summarisation, and formatting, but it does not assume professional responsibility for clinical accuracy, omissions, or inappropriate context. The governance burden sits with the organisation that deploys the system and sets the guardrails.
That distinction matters because AI scribing changes how work is produced, not who is responsible for what is signed or stored. The clinically signed record still needs a human decision-maker who can verify material facts, correct errors, and confirm that the note reflects the encounter accurately enough for care, billing, and downstream use.
What should IT, governance, and leadership own?
IT and governance teams should own the control environment around the scribe, including where notes are stored, who can access them, how long they are retained, and what compliance rules apply. That includes configuration, auditability, and the escalation path when the output is incomplete, ambiguous, or inconsistent with the encounter.
Leadership should define scope of use before broad rollout, especially for which note types, specialties, and encounter settings are allowed. If the organisation does not define when the AI output is advisory versus operationally relied upon, accountability becomes fragmented and clinicians are left managing a workflow that the business has not governed.
Ownership also needs to cover vendor and platform controls that affect the integrity of the record, such as model updates, data handling, access restrictions, and retention commitments. In practice, governance should treat the scribe as a record-production control, not just a productivity feature.
How should note review and escalation be structured?
Clinicians should review the portions of the note that affect diagnosis, treatment, orders, and follow-up before finalising the record. The organisation should define what “reviewed” means, because a signature alone is not evidence that the clinician actually checked the generated text carefully enough to rely on it.
A practical workflow is to require human confirmation for material clinical statements, a correction path for suspected errors, and an escalation route when the AI output is unusually incomplete or low confidence. Agentic AI Security Policy Template is useful here because it frames AI use as a governed process with ownership, oversight, and retirement responsibilities.
Governance teams should also define how exceptions are handled when the AI tool is used outside the approved scope, because the risk is not only bad text but unauthorised reliance on the text. Shadow AI and AI Agent Discovery Guide is relevant for understanding how unsanctioned tools and untracked AI usage can drift beyond policy.
Risk and Threat Considerations
The main risk is responsibility drift: clinicians assume the system “handled” the note, while the organisation assumes the clinician “validated” it. That gap creates record inaccuracies, compliance exposure, and weak accountability when an error affects treatment, coding, or medicolegal review.
Failure mechanism: AI-generated text can omit context, misstate negations, or preserve plausible but incorrect details, and those errors can survive if the human review step is informal or rushed. Weak governance makes the problem worse when access, retention, and audit controls are not clearly owned.
Impact: The result can be a clinically inaccurate record, disputed responsibility after an adverse event, and inconsistent compliance with privacy, retention, and documentation obligations. At scale, even small review failures can become systemic if teams rely on the tool as a substitute for governed documentation practice.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5 and NIST AI RMF set the technical controls, while ISO/IEC 27001:2022 and ISO/IEC 42001:2023 define the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | IA-2 — Identification and Authentication (Organizational Users) | Clinician signing and note access depend on accountable user authentication. |
| AU-2 — Audit Events | AI scribe use needs traceability for who reviewed, changed, and approved the record. | |
| Recommendation — Enforce strong clinician authentication before note creation and final sign-off. Log note creation, edits, approval, and exception handling for reviewability. | ||
| ISO/IEC 27001:2022 | A.5.15 — Access control | AI scribe records require defined access boundaries and approval authority. |
| A.5.33 — Protection of records | Clinical notes are records that need integrity, retention, and governance controls. | |
| Recommendation — Define and enforce access rules for note viewing, editing, and export. Classify the note as a protected record and apply retention and integrity controls. | ||
| NIST AI RMF | GV — Govern | AI scribe use needs clear accountability, oversight, and role definition. |
| Recommendation — Assign accountable owners, approval criteria, and oversight for AI scribe deployment. | ||
| ISO/IEC 42001:2023 | 4.4 — AI management system | AI scribes need a management system that allocates responsibility and control ownership. |
| Recommendation — Establish an AI management system with explicit operational accountability. | ||
Practitioner Guidance
What to verify: Verify that every deployed scribe has a named clinical owner, a defined review requirement, and an escalation path for uncertain or incorrect output. If those elements are missing, the organisation has adopted a productivity tool without a defensible accountability model.
What good looks like: The clinician signs only after reviewing material content, governance can show who owns storage and retention, and leadership can explain when the tool may be used and when it must not be used. That is the difference between assisted documentation and uncontrolled automation.
Practitioner takeaway: Keep clinical accountability with the clinician, but keep operational control with the organisation; if either side is vague, the note may be generated quickly but it is not governed well.
Related resources from NHI Mgmt Group
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 27, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
